Congress Wealth Management LLC DE boosted its position in Exponent, Inc. (NASDAQ:EXPO – Get Rating) by 7.9% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 16,539 shares of the business services provider’s stock after acquiring an additional 1,218 shares during the period. Congress Wealth Management LLC DE’s holdings in Exponent were worth $1,649,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. CI Investments Inc. raised its stake in Exponent by 24.6% in the 4th quarter. CI Investments Inc. now owns 521 shares of the business services provider’s stock valued at $52,000 after acquiring an additional 103 shares during the period. Belpointe Asset Management LLC bought a new stake in Exponent in the 4th quarter valued at about $56,000. Eagle Bay Advisors LLC raised its stake in Exponent by 81.6% in the 4th quarter. Eagle Bay Advisors LLC now owns 721 shares of the business services provider’s stock valued at $71,000 after acquiring an additional 324 shares during the period. Point72 Hong Kong Ltd purchased a new position in Exponent during the 1st quarter valued at about $74,000. Finally, Parallel Advisors LLC grew its holdings in Exponent by 6,554.2% during the 4th quarter. Parallel Advisors LLC now owns 1,597 shares of the business services provider’s stock valued at $158,000 after buying an additional 1,573 shares in the last quarter. 88.56% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
EXPO has been the subject of a number of recent analyst reports. StockNews.com initiated coverage on Exponent in a report on Thursday, May 18th. They set a “hold” rating for the company. TheStreet lowered Exponent from a “b” rating to a “c+” rating in a report on Wednesday, May 17th. Finally, UBS Group initiated coverage on Exponent in a report on Wednesday, May 31st. They set a “neutral” rating and a $99.00 target price for the company.
Exponent Trading Down 0.7 %
Exponent (NASDAQ:EXPO – Get Rating) last issued its quarterly earnings data on Thursday, April 27th. The business services provider reported $0.56 EPS for the quarter, hitting the consensus estimate of $0.56. Exponent had a return on equity of 30.86% and a net margin of 19.39%. The company had revenue of $140.30 million during the quarter, compared to analyst estimates of $127.17 million. During the same quarter in the previous year, the firm earned $0.56 earnings per share. Exponent’s revenue was up 19.0% on a year-over-year basis. On average, analysts predict that Exponent, Inc. will post 2.1 earnings per share for the current year.
Exponent Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 23rd. Stockholders of record on Friday, June 9th were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 1.11%. The ex-dividend date was Thursday, June 8th. Exponent’s payout ratio is 53.06%.
Insider Transactions at Exponent
In other news, VP Bradley A. James sold 1,500 shares of the business’s stock in a transaction dated Monday, May 22nd. The stock was sold at an average price of $89.36, for a total transaction of $134,040.00. Following the completion of the transaction, the vice president now owns 7,584 shares of the company’s stock, valued at $677,706.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Exponent news, VP Bradley A. James sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $89.36, for a total value of $134,040.00. Following the completion of the sale, the vice president now owns 7,584 shares of the company’s stock, valued at $677,706.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Joseph Rakow sold 1,388 shares of the company’s stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $86.59, for a total value of $120,186.92. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,729 shares of company stock valued at $508,440. 2.20% of the stock is owned by corporate insiders.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Stories
- Get a free research report on Exponent from StockNews.com
- Sleep-At-Night Stock Sherwin-Williams Is Ready To Rebound
- Is Diablo IV Causing a Resurgence in Activision Blizzard Stock?
- MongoDB: An AI Play That’s About To Boil Over
- Will China’s $72 Billion EV Tax Breaks Help NIO Stock Recover?
- Five stocks we like better than Exponent
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Get Rating).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
